Anticancer agent 185
Anticancer agent 185 (compound 9d) is a glycohybrid derivative of pyrazolopyrimidine [1,5-a]. Anticancer agent 185 has good anti-breast cancer activity. Anticancer agent 185 shows good cytotoxic activity against MCF-7 cells with IC50 value of 15.3 μM[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-185.html
Solubility
10 mM in DMSO
Smiles
O=C(C)O[C@H]([C@H]([C@@H]1OC(C)=O)OC(C)=O)[C@@H](O[C@@H]1COC(C)=O)N2C=C(N=N2)COC3=CC(C4=CC=C(C=C4)Cl)=NC5=CC=NN53
Molecular Formula
C29H29ClN6O10
Molecular Weight
657.03
References & Citations
[1]Tiwari G, et al. Copper-catalyzed synthesis of pyrazolo[1,5-a]pyrimidine based triazole-linked glycohybrids: mechanistic insights and bio-applications. Sci Rep. 2024 Jan 4;14 (1) :529.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
